According to data published this week by the Centers for Disease Control and Prevention, Omicron’s more contagious subvariant, BA.2, has more than doubled in prevalence in the United States over the last two weeks and now accounts for more than 34% of Covid-19 infections that have undergone genetic sequencing. Since February 5, when it comprised roughly 1% of genetically analyzed viral samples in the United States, BA.2 has been progressively increasing as a fraction of Covid variants circulating in the country. BA.2 probably already accounts for 50% of new infections in the United States since many individuals do tests at home that are not included in official statistics, according to Ali Mokdad, an epidemiologist at the University of Washington’s Institute for Health Metrics and Evaluation. In addition, Walgreens data indicates that BA.2 is the leading variety, accounting for 51% of all positive Covid cases for the week ending March 19.
Omicron BA.2 subvariant will soon dominate in the U.S., but Fauci doesn’t expect another surge. https://www.cnbc.com/2022/03/23/covid-omicron-bapoint2-subvariant-will-soon-dominate-in-us-but-fauci-doesnt-expect-another-surge.html?fbclid=IwAR1PtlOWk2ebo9dnBoKtsqyiH_wbf5mMmWMnNjPqt03RYgVyEZ2HCwcjHtY